GME
65
3
WRK
59
3
MAC
71
4
LOW
55
6
RRC
76
-2
AEE
41
-4
AVGO
52
8
NTAP
65
4
AVY
77
2
CMS
54
-6
ABT
50
3
BXP
47
-3
PRU
47
-3
TXN
40
4
SHW
58
12
BLK
49
3
BAC
48
10
BEN
52
10
WAT
53
3
QRVO
81
7
GME
65
3
WRK
59
3
MAC
71
4
LOW
55
6
RRC
76
-2
AEE
41
-4
AVGO
52
8
NTAP
65
4
AVY
77
2
CMS
54
-6
ABT
50
3
BXP
47
-3
PRU
47
-3
TXN
40
4
SHW
58
12
BLK
49
3
BAC
48
10
BEN
52
10
WAT
53
3
QRVO
81
7
Financhill
Back

Sinopharm Group Quote, Financials, Valuation and Earnings

7 Powerhouse Stocks to Buy and Hold Forever

Get it now.
Buy
65

SHTDY
Sinopharm Group

Last Price:
13.74
Seasonality Move:
-0.66%

7 Day Trial

ALL ACCESS PASS

$ 7

NOW is the time to get in on this trillion-dollar megatrend

Get it here.

Sinopharm Group Price Quote

$13.74
+0.00 (+-1.01%)
(Updated: April 27, 2024 at 6:20 AM ET)

Sinopharm Group Key Stats

Buy
65
Sinopharm Group (SHTDY) is a Buy
Day range:
$13.65 - $13.74
52-week range:
$11.36 - $17.86
Dividend yield:
4.18%
P/E ratio:
6.70
P/S ratio:
0.00
P/B ratio:
0.81%
Volume:
8.5K
Avg. volume:
10.1K
1-year change:
-20.77%
Market cap:
$8.6B
Revenue:
$84.3B
EPS:
$0

How Much Does Sinopharm Group Make?

Data Unavailable

Is Sinopharm Group Growing As A Company?

Data Unavailable

Sinopharm Group Stock Price Performance

  • Did Sinopharm Group Stock Go Up Last Month?
    Sinopharm Group share price went up by 8.34% last month
  • Did SHTDY's Share Price Rise Over The Last Year?
    SHTDY share price fell by -20.77% over the past 1 year

What Is Sinopharm Group 52-Week High & Low?

Sinopharm Group Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Sinopharm Group?

Data Unavailable

Is Sinopharm Group Cash Flow Positive?

Data Unavailable

Sinopharm Group Return On Invested Capital

Data Unavailable

Sinopharm Group Earnings Date & Stock Price

Sinopharm Group Competitors

  • Who Are Sinopharm Group's Competitors?
    Below is a list of companies who compete with Sinopharm Group or are related in some way:
    • CASI Pharmaceuticals Inc (CASI)
    • Gracell Biotechnologies Inc (DELISTED) (GRCL:DL)
    • I-MAB (IMAB)
    • Sinovac Biotech Ltd (SVA)
    • Zai Lab Ltd (ZLAB)

Sinopharm Group Dividend Yield

Sinopharm Group Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many SHTDY shares are owned by institutional investors?
    284.5K SHTDY shares are owned by institutional investors
  • How many SHTDY shares are owned by insiders?
    0 SHTDY shares are owned by insiders